BTG Company News

Epic Code:
Sub Sector:
Market Cap:

Pharmaceuticals & Biotechnology
UK Main Market
489.221928976 GBPm

Data as of 10:00 23/09/2009. Check director details and other company announcments at BTG Website .

RNS News for BTG

Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.

Latest BTG News

BTG plc (BTG) Rating Reiterated by Deutsche Bank AG
The Cerbat Gem - 3 hours ago
BTG plc logo Deutsche Bank AG reiterated their buy rating on shares of BTG plc (LON:BTG) in a report released on Thursday.
First Manhattan Company Has Cut By $573760 Its Manpowergroup (MAN) Holding; 8 ... -

05/24/2017 06:03 AM

Focusing the Lens On This Dividend Stock: BTG plc (LSE:BTG)
Geneva Journal - 19 hours ago
Shares of BTG plc (LSE:BTG) currenty have a 10 year dividend growth rate of -99.90%. This number is calculated using the geometric average which provides the typical value of dividend growth over the specified period using the product of their values.

05/23/2017 01:21 PM

BTG plc 16.5% Potential Upside Indicated by JP Morgan Cazenove
DirectorsTalk Interviews - 21 hours ago
BTG plc with EPIC/TICKER (LON:BTG) had its stock rating noted as 'Reiterates' with the recommendation being set at 'NEUTRAL' today by analysts at JP Morgan Cazenove.
BTG plc (BTG) Rating Reiterated by JPMorgan Chase & Co. - Sports Perspectives
BTG plc (BTG) Receives Average Rating of "Buy" from Brokerages - Stock Observer

05/23/2017 11:18 AM

OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS ...
Business Wire (press release) - May 22, 2017
BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society International Conference in Washington, D.C.

05/22/2017 10:56 AM

BTG: This Is Gonna Bite
Seeking Alpha - May 3, 2017
BTG plc is a UK pharmaceutical company specializing in antivenoms, oncology drugs and treatments for varicose veins. BTG's snakebite antivenom, Crofab, has been the most significant contributor to the company's overall revenue and profitability for ...

05/03/2017 10:00 AM

Is it too late to buy BTG plc (LSE:BTG) at its April price?
Simply Wall St - Apr 28, 2017
BTG plc (LSE:BTG) is a stock well positioned for future growth, but many investors are wondering whether its last closing price of £6.82 is based on unrealistic expectations.

04/28/2017 07:22 PM